“These recent purchase orders from repeat customers demonstrate the strong market adoption of our biogas desulfurization product line,” said Brad Douville, CEO of Greenlane.
“At Greenlane, we are committed to advancing renewable natural gas by addressing the industry’s most critical technology challenges, including biogas desulfurization, which is required by every biogas project.
"Our solution is setting the standard for dependable, cost-effective hydrogen sulfide removal. Adoption began in Italy, Europe’s fastest-growing biomethane market, and is now expanding across Europe and into the Americas, reflecting the confidence customers place in our technology.”
Airdep’s proprietary DBC series biogas desulfurization product line, branded as Greenlane™ Cascade H₂S in the Americas, delivers an established and robust regenerative biogas desulfurization solution delivering high performance at low cost.
The process provides fast startup as it does not rely on sensitive biological processes and neither requires the addition of oxygen nor adds it to the treated gas.
This is critical because oxygen is difficult and costly to remove after being added in alternative approaches to H2S removal such as biological scrubbers or injection directly into the digester. Excess oxygen can lead to non-compliance with injection specifications and inability to sell gas.
